
UK cautions on rare pancreatitis risk from GLP-1 weight-loss injections
The UK MHRA warns that GLP-1 obesity drugs like Wegovy, Mounjaro, and Ozempic carry a very small but real risk of acute pancreatitis. Users should seek immediate medical attention for severe, persistent stomach pain that may radiate to the back, especially with nausea or vomiting. While hundreds of pancreatitis reports exist, none are confirmed as caused by these medicines. About 1.6 million adults in the UK are estimated to have used GLP-1 products recently. Most patients benefit and are safe, but patients should discuss benefits and risks with their prescriber and report any suspected adverse effects.








